Vivek Walimbe, Ph.D., former VP for Baxter Healthcare, to lead development of intracoronary imaging product and expand portfolio Farzad Parsaie, with three decades of med device leadership, to oversee Quality and Regulatory Affairs BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a pre-commercial medical imaging company focused on optical and computational insights for the […]
Financial
Appendix 4C Quarterly Activity Report
Financial and Operational Highlights for Quarter Ended September 30, 2021 NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the first quarter ended September 30, 2021, and an update on its pipeline […]
Merit Medical Reports Results For Quarter Ended September 30, 2021
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020 Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020 Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020 Q3 2021 non-GAAP EPS* of $0.52, compared to […]
Edwards Lifesciences Reports Third Quarter Results
IRVINE, Calif., Oct. 27, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2021. Third Quarter Highlights and 2021 Outlook Sales grew 15 percent to $1.3 billion; underlying1 sales grew 14 percent TAVR sales grew 15 percent; underlying 14 percent U.S. TAVR sales grew 12 percent; OUS approximately 20 […]
Boston Scientific Announces Results For Third Quarter 2021
MARLBOROUGH, Mass., Oct. 27, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported basis, 9.7 percent on an operational1 basis and 10.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net […]
Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended September 30, 2021. Q2 financial summary and operational highlights: Revenue for the quarter totaled $248.1 million, an increase of 18% compared to $209.8 million during the same period of […]
CinCor Pharma Appoints Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer
CINCINNATI, Oct. 28, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer (EVP, CFO and CBDO). “Terry gained broad financial and operational leadership experience at several high-profile and start-up companies, including in […]
Teleflex Reports Third Quarter 2021 Results and Full Year Outlook
WAYNE, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter financial summary Reported revenues of $700.3 million, up 11.5% year-over-year; up 10.3% on a constant currency basis GAAP diluted EPS from continuing operations of […]
Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital
Investment to support Cardurion’s further evolution into a cardiovascular leader BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced it has received a private investment […]
Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
Reports Third Quarter Revenues of $11.6 Billion, an Increase of 10% YoY Posts Third Quarter Earnings Per Share of $0.69 and Non-GAAP EPS of $2.00 Advances Product Pipeline with Significant Regulatory and Clinical Milestones Achieves FDA Priority Review for Third Distinct Checkpoint Inhibitor, Relatlimab and Nivolumab Fixed-Dose Combination, as Treatment for […]
